Hatoum N S, Davis W M
Res Commun Chem Pathol Pharmacol. 1979 May;24(2):251-7.
A previous report of a lethal potentiation between sublethal doses of morphine and the beta-adrenergic blocker propranolol was confirmed for Sprague-Dawley rats. An alpha-adrenergic blocker, phentolamine, also showed a lesser but significant potentiation, as did a moderate dose of atropine. No synergism was noted between morphine and methylatropine, haloperidol or methysergide. Phentolamine and a lower dose of atropine, which did not synergize with morphine, both added significantly to the lethality of the combination of morphine and propranolol, whereas methylatropine, haloperidol and methysergide had no significant effect to synergize or antagonize mortality.
对于斯普拉格-道利大鼠,先前关于亚致死剂量吗啡与β-肾上腺素能阻滞剂普萘洛尔之间致死性增强作用的报告得到了证实。α-肾上腺素能阻滞剂酚妥拉明也显示出较小但显著的增强作用,中等剂量的阿托品也是如此。未观察到吗啡与甲基阿托品、氟哌啶醇或麦角新碱之间有协同作用。酚妥拉明和较低剂量的阿托品虽不与吗啡协同作用,但二者均显著增加了吗啡与普萘洛尔联合用药的致死性,而甲基阿托品、氟哌啶醇和麦角新碱对协同或拮抗死亡率均无显著影响。